Herpes simplex virus type 1 disseminates from the cornea to the CNS in mice by thwarting type III interferon immune defenses
- Cell Rep. 2025 Nov 18;44(12):116581. doi: 10.1016/j.celrep.2025.116581.
- 1. Department of Immunology, International Cancer Center, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong Province 518055, China; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong Province 518055, China.
- 2. Department of Immunology, International Cancer Center, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong Province 518055, China.
- 3. Department of Immunology, International Cancer Center, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong Province 518055, China. Electronic address: [email protected].
Herpes simplex virus type 1 (HSV-1) can spread to the central nervous system (CNS) through the cornea to induce neurological diseases, but how HSV-1 overcomes corneal innate immunity to enter the CNS remains unclear. We report that HSV-1-infected cell protein 0 (ICP0) upregulates corneal suppressor of cytokine signaling 1 (SOCS1) and SOCS3 expression, which inhibits stimulator of interferon genes (STING)-interferon-λ (IFN-λ) signaling to promote virus escape to the CNS. Mechanistically, SOCS3 interacts with STING and induces K48-linked ubiquitination of STING at Lys275, which promotes STING degradation, ultimately suppressing corneal IFN-λ production. SOCS1 inhibits STAT1 activation against corneal IFN-λ Antiviral responses. Administration of a STING agonist or IFN-λ preserves the corneal epithelial barrier and limits viral dissemination to the CNS. These findings elucidate an HSV-1 immune evasion mechanism in the cornea and highlight the potential of enhancing IFN-λ responses to prevent viral propagation to the CNS.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer
-
target: STINGResearch Areas: Inflammation/Immunology
-
target: STINGResearch Areas: Inflammation/Immunology